Evidence map›Paper›PMID 41632531›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Calorie Restriction Leads to Degradation of Mutant Uromodulin and Ameliorates Inflammation and Fibrosis in UMOD -Related Kidney Disease.

Mariapia Giuditta Cratere, Benedetta Perrone, Barbara Canciani, Céline Schaeffer, Luca Rampoldi

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariapia Giuditta CratereMolecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-7326-9965
Benedetta PerroneMolecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Barbara CancianiIRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy.ORCID 0000-0003-1942-1174
Céline SchaefferMolecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-5883-3951
Luca RampoldiMolecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-0544-7042

Funding

Fondazione Telethon GMR23T2167Ministero della Salute RF-2021-12372538Ministero dell'Università e della Ricerca Investment PE8 -Project Age-It: "Aging Well in an Aging Society" [DM 1557 October 11, 2022] in the context of the National Recovery and Resilience Plan (PNRR)
6 · The paper itself

Abstract

key pointsCalorie restriction stimulated autophagy and degradation of mutant uromodulin, leading to amelioration of cell stress and tubular damage. At early disease stage, calorie restriction largely reverted autosomal dominant tubulointerstitial kidney disease (ADTKD)- UMOD phenotype, preventing inflammation, fibrosis, and kidney function decline. At advanced disease stage, calorie restriction significantly delayed disease progression and worsening of kidney function.

backgroundMutations in UMOD , encoding uromodulin, lead to autosomal dominant tubulointerstitial kidney disease (ADTKD), a genetic cause of kidney failure. UMOD mutations have a common gain-of-toxic-function effect, causing mutant uromodulin retention in the endoplasmic reticulum (ER). This leads to ER stress, alteration of protein homeostasis and mitochondrial dynamics, defective autophagy, and increased cell death. Calorie restriction exerts a beneficial role in diseases characterized by accumulation of pathogenic protein and inflammation, by modulating several pathways, including autophagy induction and suppression of inflammation and fibrosis. Given the relevance of these features in ADTKD, we investigated the effect of calorie restriction on disease onset and progression.

methodsTransgenic mice expressing C147W uromodulin (Tg Umod C147W ) were subjected to a moderate (30%) calorie restriction regimen for 15 or 24 weeks, starting at different stages of disease progression.

resultsCalorie restriction restored autophagy, as shown by decreased P62 punctae and quenched mammalian target of rapamycin (mTOR) activation specifically in mutant uromodulin-expressing cells, and it recovered expression of key ER-phagy receptor genes, with a concomitant, striking reduction of mutant uromodulin ER retention. In presymptomatic Tg Umod C147W mice, calorie restriction alleviated epithelial cell stress. This, likely along with a direct anti-inflammatory effect of calorie restriction, prevented inflammation and progressive decline of kidney function. At this early disease stage, calorie restriction ameliorated the already established kidney damage and reduced fibrosis, suggesting reversal of ADTKD phenotype. Calorie restriction was also effective in significantly delaying disease progression in Tg Umod C147W mice with advanced disease and already compromised kidney function.

conclusionsCalorie restriction enhanced autophagy and uromodulin degradation, counteracting the primary effect of UMOD mutations, and significantly ameliorated kidney disease onset and progression.

Indexed as

Caloric RestrictionUromodulinAnimalsAutophagyDisease ProgressionFibrosisInflammationKidneyMaleMiceMice, TransgenicMutationTOR Serine-Threonine KinasesTOR Serine-Threonine KinasesUmod protein, mouseUromodulinCKDendoplasmic reticulumgenetic kidney diseaseinterstitial fibrosismalfolding proteinsmolecular geneticspathophysiologyprogression of renal failuretransgenic mousetubulointerstitial disease

Identifiers

PMID41632531
PMCPMC13406265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.